alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit
      32.1




**CERTIFICATION
      PURSUANT TO**




**18
      U.S.C. SECTION 1350,**




**AS
      ADOPTED PURSUANT TO**




SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002




In
      connection with the Quarterly Report of In Veritas Medical Diagnostics, Inc.
      (the "Company") on Form 10-QSB for the quarter ended January 31, 2007 as filed
      with the Securities and Exchange Commission on the date hereof (the "Report"),
      I, Graham Cooper, Chief Executive Officer of the Company, certify, pursuant
      to
      18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:




(1)
      The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities and Exchange Act of 1934; and




(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company.




A
      signed
      original of this written statement required by Section 906 has been provided
      to
      In Veritas Medical Diagnostics, Inc. and will be retained by In Veritas Medical
      Diagnostics, Inc. and furnished to the Securities and Exchange Commission or
      its
      staff upon request.




April
              25, 2007
            
            /s/ Graham
              CooperGraham
              CooperPresident
              and Chief Executive
              Officer
**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code,as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as chief executive officer of SMTC Corporation (the “Company”), does hereby certify that to the undersigned’s knowledge: 

1) the Company’s quarterly report on Form 10-Q for the quarter ended September 28, 2008 fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

2) the information contained in the Company’squarterly report on Form 10-Q for the quarter ended September 28, 2008 fairly presents, in all material respects, the financial condition and results of operations of the Company. 

 

Date: November 12, 2008 

A signed original of this written statement required by Section 906 has been provided to SMTC Corporation and will be retained by SMTC Corporation and furnished to the Securities and Exchange Commission or itsstaff upon request.
Exhibit 31.1

I, Steve Cuthbert, as Chief Executive Officer of the Company, certify
that:

  1.   I have reviewed this quarterly report on Form 10-QSB of Prologue;

  2.   Based on my knowledge, this quarterly report does not contain any
     untrue statement of a material fact or omit to state a material fact
     necessary to make the statements made, in light of the circumstances under
     which such statements were made, not misleading with respect to the period
     covered by this quarterly report;

  3.   Based on my knowledge, the financial statements, and other financial
     information included in this quarterly report, fairly present in all
     material respects the financial condition, results of operations and cash
     flows of the registrant as of, and for, the periods presented in this
     quarterly report;

  4.   The registrant's other certifying officers and I are responsible for
     establishing and maintaining disclosure controls and procedures (as
     defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
     have:

       a.   designed such disclosure controls and procedures to ensure that
          material information relating to the registrant, including its
          consolidated subsidiaries, is made known to us by others within those
          entities, particularly during the period in which this quarterly
          report is being prepared;

       b.   evaluated the effectiveness of the registrant's disclosure controls
          and procedures as of a date within 90 days prior to the filing date
          of this quarterly report (the "Evaluation Date"); and

       c.   presented in this quarterly report our conclusions about the
          effectiveness of the disclosure controls and procedures based on our
          evaluation as of the Evaluation Date;

  5.   The registrant's other certifying officers and I have disclosed,
     based on our most recent evaluation, to the registrant's auditors and the
     audit committee of registrant's board of directors (or persons performing
     the equivalent functions):

       a.   all significant deficiencies in the design or operation of
          internal controls which could adversely affect the registrant's
          ability to record, process, summarize and report financial data and
          have identified for the registrant's auditors any material
          weaknesses in internal controls; and

       b.   any fraud, whether or not material, that involves management or
          other employees who have a significant role in the registrant's
          internal controls; and

  6.   The registrant's other certifying officers and I have indicated in
     this quarterly report whether or not there were significant changes in
     internal controls or in other factors that could significantly affect
     internal controls subsequent to the date of our most recent evaluation,
     including any corrective actions with regard to significant deficiencies
     and material weaknesses.


Date: August 12, 2003                    By    /s/ Steve Cuthbert

                                       Steve Cuthbert, President
Exhibit 32.1



CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as chief
executive officer of SMTC Corporation (the Company), does hereby certify that to the undersigneds knowledge:



1) the Companys quarterly report on Form 10-Q/A for the quarter ended April 4, 2004 fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and



2) the information
contained in the Companys quarterly report on Form 10-Q for the quarter ended April 4, 2004 fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ John CaldwellJohn CaldwellPresident and Chief Executive Officer




Date: June 22, 2004



A signed original of this written statement required by Section 906 has been provided to
SMTC Corporation and will be retained by SMTC Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
Date:
December 15, 2010


Exhibit
31.2




CERTIFICATION




I, Craig
Wagenschutz, Chief Financial Officer, certify that:




1. I have
reviewed this quarterly report on Form 10-Q of Megola, Inc.;




2. Based
on my knowledge, this quarterly report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this quarterly
report;




3. Based
on my knowledge, the financial statements, and other financial information
included in this quarterly report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this quarterly report;




4. I am
responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant
and we have:




a)
designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant is made known to us by others
within the Corporation, particularly during the period in which this quarterly
report is being prepared;




b)
evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and




c)
disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter that has materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial reporting;
and




5. I have
disclosed, based on my most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of registrant's
board of directors (or persons performing the equivalent function):




a) all
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the registrant's ability to record, process, summarize and
report financial information; and




b) any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal control over financial
reporting.




Date:
      December 15, 2010/s/
      CRAIG WAGENSCHUTZCraig
      WagenschutzChief
      Financial Officer
Electronically Filed

Intermediate Court of Appeals

CAAP-12-0000984

31-JAN-2014

08:37 AM
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Postal Service

# AGENCY:

                        Postal ServiceTM.                    

# ACTION:

Notice.

# SUMMARY:

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

# DATES:

*Date of required notice:*                         February 8, 2024.                    

# FOR FURTHER INFORMATION CONTACT:

Sean Robinson, 202-268-8405.

# SUPPLEMENTARY INFORMATION:

                    The United States Postal Service® hereby gives notice that, pursuant to 39 U.S.C.                           ( print page 8730)                        3642 and 3632(b)(3), on January 30, 2024, it filed with the Postal Regulatory Commission a                     *USPS Request to Add Priority Mail & USPS Ground Advantage® Contract 178 to Competitive Product List.*                     Documents are available at                     *www.prc.gov,*                     Docket Nos. MC2024-171, CP2024-177.                

Sean Robinson,

Attorney, Corporate and Postal Business Law.

[FR Doc. 2024-02537 Filed 2-7-24; 8:45 am]

BILLING CODE 7710-12-P
<PAGE>
                                                                               .
                                                                               .
                                                                               .

                                                                      EXHIBIT 21

                         SUBSIDIARIES OF THE REGISTRANT

<TABLE>
<CAPTION>
NAME OF SUBSIDIARY                       STATE OF INCORPORATION         DOING BUSINESS AS
-------------------------------------------------------------------------------------------
<S>                                      <C>                            <C>
ICG Communications, Inc.                        Delaware                        -

ICG Canadian Acquisition, Inc.                  Delaware                        -

ICG Holdings, Inc.                              Colorado                        -

ICG Telecom Group, Inc.                         Colorado                        -

NikoNet, L.L.C.                                  Georgia                        -

ICG Telecom Group of Virginia                   Virginia                        -

ICG Consolidated, Inc.                          Delaware                        -

ICG ChoiceCom Management, L.L.C.                Delaware                        -

ICG ChoiceCom, L.P.                             Delaware                        -

ICG Equipment, Inc.                             Colorado                        -

ICG Mountain View, Inc.                         Colorado                        -
</TABLE>
<PAGE>


                                                                    Exhibit 23.1


                          INDEPENDENT AUDITORS' CONSENT

We consent to incorporation by reference in the registration statement
(No. 333-11375) on Form S-8, registration statement (No. 333-35669) on Form S-8,
registration statement (No. 333-47695) on Form S-8, registration statement
(No. 333-84711 on Form S-3, registration statement (No. 333-65011) on Form S-3,
registration statement (No. 333-52403) on Form S-3, and registration statement
(No. 333-4854-LA) on Form S-3 of Maxim Pharmaceuticals, Inc. (a development
stage company) of our report dated November 19, 1999 relating to the balance
sheets of Maxim Pharmaceuticals, Inc. as of September 30, 1999 and 1998, and the
related statements of operations, stockholders' equity (deficit), and cash flows
for each of the years in the three-year period ended September 30, 1999, and
from the period from inception (October 23, 1989) through September 30, 1999,
which report appears in the September 30, 1999 annual report on Form 10-K of
Maxim Pharmaceuticals, Inc.


/s/  KPMG LLP
-------------

San Diego, California
December 22, 1999
**Exhibit 31.1**
**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**
I, Marshall D. Sorokwasz, certify that:
1. I have reviewed the quarterly report on Form 10-Q for the quarterended May 31, 2005 of Impreso, Inc. (the “Report”); 2. Based on my knowledge, the Report does not contain any untruestatement of a material fact or omit to state a material factnecessary to make the statements made, in light of thecircumstances under which such statements were made, notmisleading with respect to the period covered by the Report; 3. Based on my knowledge, the financial statements, and otherfinancial information included in the Report, fairly present inall material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, theperiods presented in the Report; 4. The registrant’s other certifying officer and I are responsiblefor establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:
 a) Designed such disclosure controls and procedures, orcaused such disclosure controls and procedures to bedesigned under our supervision, to ensure thatmaterial information relating to the registrant,including its consolidated subsidiaries, is made knownto us by others within those entities, particularlyduring the period in which this report is beingprepared;  b) Evaluated the effectiveness of the registrant’sdisclosure controls and procedures and presented inthe Report our conclusions about the effectiveness ofthe disclosure controls and procedures, as of the endof the period covered by the Report based on suchevaluation; and  c) Disclosed in the Report any change in the registrant’sinternal control over financial reporting thatoccurred during the registrant’s most recent fiscalquarter (the registrant’s fourth fiscal quarter in thecase of an annual report) that has materiallyaffected, or is reasonably likely to materiallyaffect, the registrant’s internal control overfinancial reporting;
5. The registrant’s other certifying officer and I have disclosed,based on our most recent evaluation of internal control overfinancial reporting, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or personsperforming the equivalent functions):
 a) All significant deficiencies and material weaknessesin the design or operation of internal controls overfinancial reporting which are reasonably likely toadversely affect the registrant’s ability to record,process, summarize and report financial information;and  b) Any fraud, whether or not material, that involvesmanagement or other employees who have a significantrole in the registrant’s internal control overfinancial reporting.
6. Item 4 Controls and Procedures in the registrant’s Form 10-Q is incorporated hereinby reference.        Date: July 15, 2005 /s/ Marshall D. Sorokwasz   **Marshall D. Sorokwasz**   **Chief Executive Officer and President**
<PAGE>

                                                                    EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of uWink, Inc. (the "Company") on Form
10-QSB/A for the quarter ending June 30, 2006 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Peter F. Wilkniss,
Chief Financial Officer and Chief Accounting Officer of the Company, hereby
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)      The report fully complies with the requirements of Section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

(2)      The information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.


December 8, 2006                                    By: /s/ PETER F. WILKNISS
                                                        ------------------------
                                                        Peter F. Wilkniss
                                                        Chief Financial Officer
                                                        Chief Accounting Officer
NUMBER 13-14-00229-CV

COURT OF APPEALS

THIRTEENTH DISTRICT OF TEXAS

CORPUS CHRISTI - EDINBURG

____________________________________________________________

ARLYNE JOHNSON, Appellant,

v.

OC GOLF, LLC, Appellee. 

____________________________________________________________

On appeal from the County Court at Law No. 5

of Hidalgo County, Texas.

____________________________________________________________

MEMORANDUM OPINION

Before Justices Rodriguez, Benavides, and Perkes

Memorandum Opinion Per Curiam

The appellant's brief in the above cause was due on September 24, 2014. On 

October 2, 2014, the Clerk of the Court notified appellant that the brief had not been timely 

filed and that the appeal was subject to dismissal for want of prosecution under Texas 

Rule of Appellate Procedure 38.8(a)(1), unless within ten days from the date of receipt of 

this letter, appellant reasonably explained the failure and the appellee was not 
2

significantly injured by the appellant's failure to timely file a brief. To date, no response 

has been received from appellant. 

Appellant has failed to either reasonably explain her failure to file a brief, file a 

motion for extension of time to file her brief, or file her brief. Accordingly, the appeal is 

DISMISSED FOR WANT OF PROSECUTION. See TEX. R. APP. P. 38.8(a), 42.3(b). 

PER CURIAM

Delivered and filed the 30th

day of October, 2014.
[Federal Register Volume 89, Number 25 (Tuesday, February 6, 2024)]
[Notices]
[Page 8245]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02285]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Senior Healthcare Innovation Consortium

    Notice is hereby given that, on January 9, 2024, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Senior Healthcare 
Innovation Consortium (``SHIC'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, Deep Level Corp., Long Beach, CA; Mellitus 
Health, Inc., Beverly Hills, CA; Polaris Alpha Advanced Systems, Inc., 
Fredericksburg, VA; PortaVision Medical, Metairie, LA; and Sekond Skin 
Society, Walkerton, CA, have been added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and SHIC intends to file additional 
written notifications disclosing all changes in membership.
    On November 02, 2022, SHIC filed its original notification pursuant 
to section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to section 6(b) of the Act on 
November 23, 2022 (87 FR 71677).
    The last notification was filed with the Department on October 5, 
2023. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on December 15, 2023 (88 FR 86930).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-02285 Filed 2-5-24; 8:45 am]
BILLING CODE P